ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO670

Crescentic IgA Nephropathy (cIgAN) in a Patient With COVID-19 Infection

Session Information

Category: Glomerular Diseases

  • 1302 Glomerular Diseases: Immunology and Inflammation

Authors

  • Chau, Sally, UCLA Medical Center Olive View, Sylmar, California, United States
  • Villano, Svetlana O., UCLA Medical Center Olive View, Sylmar, California, United States
  • Valluri, Vinod K., UCLA Medical Center Olive View, Sylmar, California, United States
  • Bath, Kulwant Singh, UCLA Medical Center Olive View, Sylmar, California, United States
  • Haghi, Masoud, UCLA Medical Center Olive View, Sylmar, California, United States
  • Singh, Nisha Mei, UCLA Medical Center Olive View, Sylmar, California, United States
  • Hou, Jean, Cedars-Sinai Medical Center, Los Angeles, California, United States
  • Mendoza, Susana M., UCLA Medical Center Olive View, Sylmar, California, United States
  • Jafari, Golriz, UCLA Medical Center Olive View, Sylmar, California, United States
  • Kamarzarian, Anita, UCLA Medical Center Olive View, Sylmar, California, United States
  • Pham, Phuong-Thu T., University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Pham, Phuong-Chi T., UCLA Medical Center Olive View, Sylmar, California, United States
Introduction

COVID19 infection has been linked to various glomerulonephropathies (GN) including collapsing focal segmental glomerulosclerosis, pauciimmune crescentic glomerulonephritis, and possibly minimal change disease and IgA nephropathy.

Case Description

A 57-year-old obese man with hypertension, hyperlipidemia, prediabetes, chronic obstructive pulmonary disease, illicit drug use, status post Pfizer COVID vaccine (1st dose 4m prior, 2nd dose 3w later), and COVID19 infection 7w prior, presented with an acute onset purpuric rash that began from bilateral hands and feet and progressed to arms and legs. Patient denied joint pain or abdominal discomfort.

Initial studies: Serum creatinine (Cr) 4.17 mg/dL (2.37 mg/dL 2w prior, baseline 0.93 mg/dL 4m prior). Urinalysis: > 50 red blood cells/high power field; Urine protein/Cr 4g/g, albumin/Cr >3g/g; Negative: HIV, ANCA, ANA, antiGBM, complements.
Chest CT: Bilateral multifocal consolidative opacities concerning for aspiration, multifocal bacterial or viral pneumonia, or atypical presentation of COVID19 pneumonia.
Skin biopsy: Leukocytoclastic vasculitis; No immunoreactants detected.

Patient suffered from rapid respiratory deterioration, multiple hypotensive episodes, and acute kidney injury requiring mechanical ventilation and dialysis support.
Kidney biopsy: IgA dominant immune complex mediated glomerulonephritis with focal/remote fibrous crescents; acute tubular injury.
Treatment: Intravenous methylprednisolone 250 mg x 3d, followed by oral prednisone course.
Patient recovered adequate function after 6w and was able to discontinue dialysis.

Discussion

COVID19 infection-related inflammatory response may precipitate GN in susceptible individuals. Crescentic IgAN is known to be associated with acute inflammatory conditions involving lungs, gastrointestinal tract, and skin. The timeline for the development of cIgAN herein raises suspicion for COVID19 infection/pneumonia as the inciting event.